SHL Share Price Performance
AU$20.14
-4.89 (-19.54%)
21.8% undervalued intrinsic discount
AU$25.74
Fair Value
Price AU$20.14
AnalystConsensusTarget AU$25.74
Choppy AU$30.00
AnalystLowTarget AU$23.00
Fair ValueAU$25.74
Share Pricen/a
Sonic Healthcare Limited Stock Price
- 4 Narratives written by author
- 4 Comments on narratives written by author
- 121 Fair Values set on narratives written by author
SHL Community Narratives
AN
Fair Value AU$25.74 21.8% undervalued intrinsic discount
Digital Pathology And Global Expansion Will Define Healthcare
1users have liked this narrative
4users have commented on this narrative
61users have followed this narrative
CH
Fair Value AU$30 32.9% undervalued intrinsic discount
Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value AU$23 12.4% undervalued intrinsic discount
Genetics And Radiology Services Will Support Steady Margins And Fairly Priced Prospects
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.
Sonic Healthcare stands as the world’s third-largest medical diagnostics company, operating an extensive network of pathology labs, radiology centers, and primary care medical practices across Australia, the US, Germany, Switzerland, and the UK. Founded in 1987, the company has spent over three decades executing a disciplined acquisition strategy to become a cornerstone of global healthcare infrastructure.Read more
3
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Digital Pathology And Global Expansion Will Define Healthcare
Key Takeaways Expansion of specialty and genetic testing alongside international acquisitions is strengthening service mix, diversifying revenue, and driving margin growth. Technological investments and major contract wins are boosting efficiency, market share, and profitability in an increasingly consolidated diagnostic sector.Read more
634
users have viewed this narrative1users have liked this narrative
4users have commented on this narrative
61users have followed this narrative
AN
AU$25.74
21.8% undervalued intrinsic discount
Fair Value
Revenue
5.05% p.a.
Profit Margin
6.59%
Future PE
21.23x
Price in 2029
AU$31.4
Radiology And Genetics Demand Will Transform This Diagnostics Consolidator Over The Next Decade
Catalysts About Sonic Healthcare Sonic Healthcare is a global medical diagnostics company focused on laboratory pathology, radiology and clinical services across multiple countries. What are the underlying business or industry changes driving this perspective?Read more
91
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$33.3
39.5% undervalued intrinsic discount
Fair Value
Revenue
9.64% p.a.
Profit Margin
7.26%
Future PE
21.02x
Price in 2029
AU$40.42
Genetics And Radiology Services Will Support Steady Margins And Fairly Priced Prospects
Catalysts About Sonic Healthcare Sonic Healthcare is a global medical diagnostics company focused on pathology, radiology and primary care services across several major healthcare markets. What are the underlying business or industry changes driving this perspective?Read more
60
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AU$23
12.4% undervalued intrinsic discount
Fair Value
Revenue
8.06% p.a.
Profit Margin
5.71%
Future PE
19.3x
Price in 2029
AU$27.92
Trending Discussion
Recently Updated Narratives
CH
Sonic Healthcare Is Priced for Yesterday. Its AI Is Built for Tomorrow.
Fair Value: AU$30 32.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SHL: Upcoming Dividend And Stable Assumptions Will Support A Higher Future Multiple
Fair Value: AU$25.74 21.8% undervalued intrinsic discount
61 fair values setusers have set this as their fair value
4 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Radiology And Genetics Demand Will Transform This Diagnostics Consolidator Over The Next Decade
Fair Value: AU$33.3 39.5% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sonic Healthcare Limited Key Details
About SHL
- Founded
- 1934
- Employees
- 45000
- CEO
- WebsiteView website
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
